Sacheerome IPO investors who received one 1,200-share lot at ₹102 and held it saw its value rise from ₹1,22,400 to ₹4,78,500 at ₹398.75, an unrealised gain of ₹3,56,100…
Sacheerome SME IPO Delivers Multibagger Returns
Sacheerome, an NSE SME platform-listed company, has delivered substantial unrealised gains to investors who received allotment in its June 2025 initial public offering and retained their shares. The IPO, open from 9 to 11 June 2025, was priced at ₹102 per equity share, the upper end of its ₹96–102 band. With a lot size of 1,200 shares, the minimum retail application amounted to ₹1,22,400. The issue comprised a fresh issuance of 60.41 lakh shares, raising ₹61.62 crore.
Listing And Current Valuation
The stock listed on 16 June 2025 at ₹153, a 50% premium to the issue price, and closed its debut session at ₹160.55, up 57.4%. At the present market price of ₹398.75, one allotted lot is valued at ₹4,78,500 against the original outlay of ₹1,22,400 — an unrealised gain of ₹3,56,100, or roughly 291%, before brokerage, taxes and other charges. The scrip has gained 86.24% over one year. On the day reported, it opened at ₹401, touched an intraday high of ₹408 and a low of ₹397.
Why It Matters For Businesses
SME platform listings have emerged as a significant capital-raising route for smaller enterprises, and Sacheerome's experience illustrates both the fundraising potential and the sharp price discovery typical of this segment. The company's H1 FY27 numbers show total income up 9.84% year-on-year to ₹85.92 crore, EBITDA up 12.27% to ₹23.69 crore, and PAT up 12.38% to ₹16.79 crore, with EBITDA and PAT margins of 27.57% and 19.54% respectively. Management noted that trial production began in September 2026 at its new YEIDA facility, adding manufacturing capacity and dedicated infrastructure for research, application development and product evaluation. For promoters, compliance teams and prospective SME issuers, the case highlights how operational expansion and disclosure discipline accompany market valuation.
What To Watch Next
A technical analyst quoted in the report observed that the stock remains in a downtrend despite a b…
Services related to this update
Want this handled for you?
Get a free expert consultation and an exact quote within 24 hours.
Get free quote
